Abacavir-induced reversible Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome.
There are several reports of Fanconi syndrome (FS) with or without nephrogenic diabetes insipidus (NDI) in patients with human immunodeficiency virus (HIV) infection, treated with various antiretroviral medications like cidofovir, adefovir, didenosine and tenofovir. But neither FS nor NDI has been documented with abacavir therapy. We are reporting the first case of abacavir-induced reversible FS with NDI in a patient with acquired immunodeficiency syndrome, who recovered completely with supportive treatment and discontinuation of abacavir.
Ahmad
M
M
Department of Nephrology, University Health Network, University of Toronto, Ontario, Canada. mufazzal2002@yahoo.co.in
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D018500:Diabetes Insipidus, Nephrogenic / Q000150:complications*; D015224:Dideoxynucleosides / Q000009:adverse effects*; D005198:Fanconi Syndrome / Q000139:chemically induced*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D000099227:Abacavir